Product Information
LISDEXAMFETAMINE 50 MG TB CHEW is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $3.5749 per EA under NDC 00480974201. Its NADAC has been published 96 times since Oct 23, 2024.
FDA first approved this application on Aug 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480974201
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA215415FDA Approved
8/25/2023
TE Code
AB
On Market Since
9/16/2024
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 50 MG TB CHEW has been published 96 times since Oct 23, 2024, and over the history we have for it it has declined 60.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5749 per EA |
|---|---|
| All-time high | $9.0316 (Nov 13, 2024) |
| All-time low | $3.5749 (Aug 19, 2026) |
| 52-week high | $6.3156 |
| 52-week low | $3.5749 |
| Median price | $6.0736 |
| Average price | $6.5807 |
| Largest weekly change | -13.0% (Jun 17, 2026) |
| Weeks tracked | 96 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 50 MG TB CHEW?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 50 MG TB CHEW, manufactured by Teva Pharmaceuticals USA Inc., is $3.5749 per EA (NDC 00480974201), effective Aug 19, 2026.
How has the price of LISDEXAMFETAMINE 50 MG TB CHEW changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 50 MG TB CHEW has declined 60.4%. It has been tracked across 96 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 50 MG TB CHEW?
Since Oct 23, 2024, the NADAC for LISDEXAMFETAMINE 50 MG TB CHEW has ranged from a low of $3.5749 (Aug 19, 2026) to a high of $9.0316 (Nov 13, 2024), with a median of $6.0736 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 50 MG TB CHEW?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 50 MG TB CHEW in a comparable dosage form, but none are currently priced below it.
Who manufactures LISDEXAMFETAMINE 50 MG TB CHEW?
LISDEXAMFETAMINE 50 MG TB CHEW (NDC 00480974201) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.